Double Standards in Medical Research in Developing Countries
Double Standards in Medical Research in Developing Countries
复制标题
发展中国家医学研究的双重标准
DOI：
--
复制
发表时间：
2004
期刊：
影响因子：
--
通讯作者：
J. Scully
中科院分区：
文献类型：
--
作者：
J. Scully
这本书探讨了围绕由工业化国家或工业赞助的国际医学研究的设计和实施，以及在发展中国家进行的伦理争议。主要的关切是，发展中国家的研究课题可能会被利用，因为研究的赞助者采用双重标准。一个争论的焦点是，发展中国家医学研究受试者所得到的护理标准是否应该与北美和欧洲的研究受试者所得到的护理标准相同。另一个争议涉及医学研究的赞助者有义务向进行研究的发展中国家的人口提供成功的研究产品。审查的其他关切问题是，发展中国家获得知情同意的程序是否充分，以及对研究进行的事先伦理审查是否符合工业化国家既定的标准。最近的国际事态发展表明，发展中国家可以负担得起和获得基本药物，而不必实行双重标准。这是第一本研究这些问题的书，得出了大胆的结论，即医学研究中的双重标准在伦理上是不可接受的。
This book explores the ethical controversies that have surrounded the design and conduct of international medical research sponsored by industrialized countries or industry, and carried out in developing countries. The chief concern is that research subjects in developing countries may be exploited because sponsors of research employ double standards. One debate focuses on whether the standard of care provided to subjects of medical research in developing countries should be the same as that which research subjects receive in North America and Europe. Another controversy addresses the obligations of sponsors of medical research to provide the successful products of research to the population in developing countries where the research is conducted. Other concerns examined are whether the process of obtaining informed consent in developing countries is adequate, and whether prior ethical review of research meets standards that are well established in the industrialized world. Recent international developments show that essential medications can be made affordable and accessible to developing countries, and that double standards need not prevail. This is the first book to examine these issues, drawing the bold conclusion that double standards in medical research are ethically unacceptable.